In-depth market intelligence, including robust market sizing & forecast data on topics such as population health management, patient engagement, remote patient monitoring, telehealth and mHealth
Population Health Management – North America – 3Q 2017
Using vendor-led, tightly-constructed definitions, Signify Research’s just-published market report on the North American PHM market provides market estimates and forecasts for the key building blocks of a PHM solution.
Population Health Management – EMEA, Latin America and Asia Report – 2018
PHM is well developed in North America. However, there are a number of emerging markets across EMEA, Asia, the Latin America that are forecast to drive growth. This new report explores this market opportunity.
Population Health Management & Telehealth Service 2017
The PHM and telehealth intelligence service is a subscription services that provides ongoing data, insights and analysis on the global population health management & telehealth markets
Acute, Community and Home Telehealth – World – 2017
This is a proposal for a market report on the global market for Acute, Community & Home Telehealth. The report examines the use of telehealth platforms, services & hardware across the care continuum.
Drivers of Population Health Management in the UK
What are the key drivers and challenges for PHM vendors looking to sell to the UK?
Avizia’s Acquisition of Carena – The Signify View
Signify Research’s take on telehealth platform and hardware supplier Avizia’s acquisition of virtual care provider Carena.
Medecision Acquires AxisPoint Health’s Platform Clients
Signify Research’s take on Medecision’s acquisition of AxisPoint Health’s AXIS platform and customers, and what this means for both companies.
PHM Opportunities Outside the US
With the US PHM market starting to approach maturity, where are the opportunities for vendors to expand their footprint internationally?
PHM Growth Slows Down in 1H 2017
Signify Research will publish its Q2 2017 North American PHM market report in the coming weeks. A key question is the extent to which uncertainly around US health legislation reform has impacted the market.